These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 19876976)

  • 1. Stabilization of G-quadruplex DNA with platinum(II) Schiff base complexes: luminescent probe and down-regulation of c-myc oncogene expression.
    Wu P; Ma DL; Leung CH; Yan SC; Zhu N; Abagyan R; Che CM
    Chemistry; 2009 Dec; 15(47):13008-21. PubMed ID: 19876976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based design of platinum(II) complexes as c-myc oncogene down-regulators and luminescent probes for G-quadruplex DNA.
    Wang P; Leung CH; Ma DL; Yan SC; Che CM
    Chemistry; 2010 Jun; 16(23):6900-11. PubMed ID: 20437426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 9-N-Substituted berberine derivatives: stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc.
    Ma Y; Ou TM; Hou JQ; Lu YJ; Tan JH; Gu LQ; Huang ZS
    Bioorg Med Chem; 2008 Aug; 16(16):7582-91. PubMed ID: 18674916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
    Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
    Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum(II) complexes with dipyridophenazine ligands as human telomerase inhibitors and luminescent probes for G-quadruplex DNA.
    Ma DL; Che CM; Yan SC
    J Am Chem Soc; 2009 Feb; 131(5):1835-46. PubMed ID: 18998644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of G-quadruplex DNA and down-regulation of oncogene c-myc by quindoline derivatives.
    Ou TM; Lu YJ; Zhang C; Huang ZS; Wang XD; Tan JH; Chen Y; Ma DL; Wong KY; Tang JC; Chan AS; Gu LQ
    J Med Chem; 2007 Apr; 50(7):1465-74. PubMed ID: 17346034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of triethylene tetraamine on the G-quadruplex structure in the human c-myc promoter.
    Yin F; Liu J; Deng X; Wang J
    J Biochem; 2007 May; 141(5):669-74. PubMed ID: 17339229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platination of telomeric sequences and nuclease hypersensitive elements of human c-myc and PDGF-A promoters and their ability to form G-quadruplexes.
    Viglasky V
    FEBS J; 2009 Jan; 276(2):401-9. PubMed ID: 19054066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder.
    Kang HJ; Park HJ
    Biochemistry; 2009 Aug; 48(31):7392-8. PubMed ID: 19496619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, structural characterization, and quadruplex DNA binding studies of platinum(II)-terpyridine complexes.
    Suntharalingam K; White AJ; Vilar R
    Inorg Chem; 2009 Oct; 48(19):9427-35. PubMed ID: 19728717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disubstituted 1,8-dipyrazolcarbazole derivatives as a new type of c-myc G-quadruplex binding ligands.
    Chen WJ; Zhou CX; Yao PF; Wang XX; Tan JH; Li D; Ou TM; Gu LQ; Huang ZS
    Bioorg Med Chem; 2012 May; 20(9):2829-36. PubMed ID: 22484007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silencing c-MYC expression by targeting quadruplex in P1 promoter using locked nucleic acid trap.
    Kumar N; Patowary A; Sivasubbu S; Petersen M; Maiti S
    Biochemistry; 2008 Dec; 47(50):13179-88. PubMed ID: 19053274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inducement of G-quadruplex DNA forming and down-regulation of oncogene c-myc by bile acid-amino acid conjugate-BAA.
    Tian M; Zhang X; Li Y; Ju Y; Xiang J; Zhao C; Tang Y
    Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):190-9. PubMed ID: 20408050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell proliferation by quindoline derivative (SYUIQ-05) through its preferential interaction with c-myc promoter G-quadruplex.
    Ou TM; Lin J; Lu YJ; Hou JQ; Tan JH; Chen SH; Li Z; Li YP; Li D; Gu LQ; Huang ZS
    J Med Chem; 2011 Aug; 54(16):5671-9. PubMed ID: 21774525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the equilibrium between G-quadruplex and duplex DNA in promoter of human c-myc oncogene by a pyrene derivative.
    Zhang Z; He X; Yuan G
    Int J Biol Macromol; 2011 Dec; 49(5):1173-6. PubMed ID: 21683090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platinum(II) phenanthroimidazoles for targeting telomeric G-quadruplexes.
    Castor KJ; Mancini J; Fakhoury J; Weill N; Kieltyka R; Englebienne P; Avakyan N; Mittermaier A; Autexier C; Moitessier N; Sleiman HF
    ChemMedChem; 2012 Jan; 7(1):85-94. PubMed ID: 22052801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 12-N-Methylated 5,6-dihydrobenzo[c]acridine derivatives: a new class of highly selective ligands for c-myc G-quadruplex DNA.
    Liao SR; Zhou CX; Wu WB; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2012 Jul; 53():52-63. PubMed ID: 22513122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element.
    Hurley LH; Von Hoff DD; Siddiqui-Jain A; Yang D
    Semin Oncol; 2006 Aug; 33(4):498-512. PubMed ID: 16890804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of metal coordination on the interaction of substituted phenanthroline and pyridine ligands with quadruplex DNA.
    Reed JE; White AJ; Neidle S; Vilar R
    Dalton Trans; 2009 Apr; (14):2558-68. PubMed ID: 19319401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Furan based cyclic homo-oligopeptides bind G-quadruplex selectively and repress c-MYC transcription.
    Agarwal T; Roy S; Chakraborty TK; Maiti S
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4346-9. PubMed ID: 20615700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.